| Therapeutic peptides: Historical perspectives, current development trends, and future directions |
247 |
| 3-Triazole-containing hybrids as leads in medicinal chemistry: A recent overview |
69 |
| Peptide therapeutics from venom: Current status and potential |
54 |
| The recent progress of isoxazole in medicinal chemistry |
42 |
| Biocatalysis for synthesis of pharmaceuticals |
28 |
| Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer's disease (1998-2018) |
27 |
| Developing hybrid molecule therapeutics for diverse enzyme inhibitory action: Active role of coumarin-based structural leads in drug discovery |
23 |
| Rational approaches, design strategies, structure activity relationship and mechanistic insights for therapeutic coumarin hybrids |
22 |
| Peptide chemistry toolbox - Transforming natural peptides into peptide therapeutics |
22 |
| Improving oral bioavailability of cyclic peptides by N-methylation |
21 |
| Nose-to-brain peptide delivery - The potential of nanotechnology |
20 |
| Structure-activity relationships for analogs of the tuberculosis drug bedaquiline with the naphthalene unit replaced by bicyclic heterocycles |
20 |
| Seek & Destroy, use of targeting peptides for cancer detection and drug delivery |
19 |
| 5-Dialkoxypyridine analogues of bedaquiline are potent antituberculosis agents with minimal inhibition of the hERG channel |
18 |
| Synthesis, antiproliferative and apoptosis induction potential activities of novel bis(indolyl) hydrazide-hydrazone derivatives |
16 |
| Structure-activity relationships for unit C pyridyl analogues of the tuberculosis drug bedaquiline |
16 |
| Personalized neoantigen vaccines: A new approach to cancer immunotherapy |
15 |
| 5-Adamantan thiadiazole-based thiazolidinones as antimicrobial agents. Design, synthesis, molecular docking and evaluation |
15 |
| Facilely accessible quinoline derivatives as potent antibacterial agents |
14 |
| Discovery and structural characterization of peficitinib (ASP015K) as a novel and potent JAK inhibitor |
14 |
| A review on the hybrids of hydroxycinnamic acid as multi-target-directed ligands against Alzheimer's disease |
13 |
| Discovery of new ureido benzenesulfonamides incorporating 5-triazine moieties as carbonic anhydrase I, II, IX and XII inhibitors |
13 |
| Antitussive and expectorant activities of licorice and its major compounds |
13 |
| Podophyllotoxin derivatives as an excellent anticancer aspirant for future chemotherapy: A key current imminent needs |
12 |
| Molecular modeling, synthesis, antibacterial and cytotoxicity evaluation of sulfonamide derivatives of benzimidazole, indazole, benzothiazole and thiazole |
12 |
| Discovery of novel thienoquinoline-2-carboxamide chalcone derivatives as antiproliferative EGFR tyrosine kinase inhibitors |
12 |
| Biocatalysts for the pharmaceutical industry created by structure-guided directed evolution of stereoselective enzymes |
12 |
| Macrocyclic alpha helical peptide therapeutic modality: A perspective of learnings and challenges |
12 |
| Dispiropyrrolidinyl-piperidone embedded indeno[2-b]quinoxaline heterocyclic hybrids: Synthesis, cholinesterase inhibitory activity and their molecular docking simulation |
12 |
| A Ru(II) polypyridyl complex bearing aldehyde functions as a versatile synthetic precursor for long-wavelength absorbing photodynamic therapy photosensitizers |
11 |
| An insight into medicinal chemistry of anticancer quinoxalines |
11 |
| Characterising covalent warhead reactivity |
11 |
| Unveiling the druggable RNA targets and small molecule therapeutics |
11 |
| Fluoroquinolones structural and medicinal developments (2013-2018): Where are we now? |
11 |
| Machine learning-enabled discovery and design of membrane-active peptides |
11 |
| A review on flavones targeting serine/threonine protein kinases for potential anticancer drugs |
11 |
| Curcumin derivatives and A beta-fibrillar aggregates: An interactions' study for diagnostic/therapeutic purposes in neurodegenerative diseases |
11 |
| Design, synthesis and anticancer evaluation of acridine hydroxamic acid derivatives as dual Topo and HDAC inhibitors |
10 |
| Fusarithioamide B, a new benzamide derivative from the endophytic fungus Fusarium chlamydosporium with potent cytotoxic and antimicrobial activities |
10 |
| Synthesis and fungicidal activity of novel pyrazole derivatives containing 5-Phenyl-2-Furan |
10 |
| Synthesis and SAR of new isoxazole-triazole bis-heterocyclic compounds as analogues of natural lignans with antiparasitic activity |
10 |
| Cereblon versus VHL: Hijacking E3 ligases against each other using PROTACs |
10 |
| Prospects of PASylation (R) for the design of protein and peptide therapeutics with extended half-life and enhanced action |
10 |
| A strategic approach to the synthesis of ferrocene appended chalcone linked triazole allied organosilatranes: Antibacterial, antifungal, antiparasitic and antioxidant studies |
10 |
| Induction of apoptosis by pyrazolo[4-d]pyridazine derivative in lung cancer cells via disruption of Bcl-2/Bax expression balance |
10 |
| Synthesis and antibacterial studies of teixobactin analogues with non-isostere substitution of enduracididine |
9 |
| Isolation and structure determination of a new lasso peptide specialicin based on genome mining |
9 |
| Cathepsin B: Active site mapping with peptidic substrates and inhibitors |
9 |
| Synthesis and characterization of pyridoxine, nicotine and nicotinamide salts of dithiophosphoric acids as antibacterial agents against resistant wound infection |
9 |
| Anticancer profile of newly synthesized BRAF inhibitors possess 5-(pyrimidin-4-yl)imidazo[1-b]thiazole scaffold |
9 |
